补充图谱确定了依赖interleukin-6的替代途径失调作为COVID-19的一个关键可药物治疗的特征
Karel F A Van Damme1,2,3, Levi Hoste1,4, Jozefien Declercq1,2,3
1Department of Internal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
Science translational medicine
|August 23, 2023
概括
COVID-19补充系统失调,主要是通过替代途径,驱动组织损伤. 向C5补充剂可能会减少严重病例的疾病严重程度和上皮损伤.
科学领域:
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
- 基因组学就是基因组学.
背景情况:
- 补体系统对于天生的免疫力至关重要,在严重疾病中可以加剧组织损伤.
- 了解补充在COVID-19病变发生过程中的作用,特别是在重症患者中,对于治疗开发至关重要.
研究的目的:
- 阐明特定的补充路径和驱动COVID-19病理的细胞源.
- 确定补充剂激活的上游调节者,并评估补充剂抑制的治疗潜力.
主要方法:
- 患者组织的蛋白质和单细胞测序分析.
- 在呼吸系统恶化期间映射补充变化.
- 研究IL-6和STAT信号在补充反应中的作用.
- 关于补充C5抑制的探索性蛋白质学研究.
主要成果:
- 在COVID-19中补充激活主要由替代途径介导.
- 详细地图表的补体变化和细胞生产 (肺细胞,肝脏) 被生成.
- 鉴定出interleukin-6 (IL-6) 和STAT1/3信号是补体失调的上游驱动因素.
- 补充C5抑制显示了减少上皮损伤和疾病严重程度标志物的潜力.
结论:
- 补体失调是COVID-19引起的组织损伤的核心机制.
- 已确定的上游驱动因素将补充激活与现有的COVID-19疗法联系起来.
- 补充C5代表了严重COVID-19的有希望的治疗标.
相关概念视频
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
Pneumonia II: Pathophysiology
336
The pathophysiology of pneumonia involves the following steps:
336
COPD: Pathogenesis and Clinical Features
341
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
341
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K


